KAPA financials

Kairos Pharma (KAPA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

KAPA income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$5.57M-$5.45M-2.10
2024––-$2.34M-$2.60M-1.61
2023––-$1.71M-$1.81M-1.19